What are the considerations for anticoagulant therapy in patients with sickle cell anemia, and how does it affect their thrombotic and bleeding risks?
Gaurav ChauhanContributor
What are the considerations for anticoagulant use in patients with sickle cell anemia?
Share
Patients with sickle cell anemia face increased thrombotic risk due to blood cell abnormalities, yet are also at risk for bleeding due to potential blood vessel damage. Anticoagulant therapy must be carefully balanced to manage both risks.